The 2019 James W. Freston Conference: Food at the Intersection of Gut Health and Disease

TY - JOUR

T1 - The 2019 James W. Freston Conference

T2 - Food at the Intersection of Gut Health and Disease

AU - Freston Conference Faculty

AU - Mullin, Gerard E.

AU - Chey, William D.

AU - Crowe, Sheila E.

AU - Ananthakrishan, Ashwin

AU - Garcia-Bailo, Bibiana

AU - Dellon, Evan S.

AU - DiBaise, John

AU - Fasano, Alessio

AU - Haller, Emily

AU - Hamilton, Matthew J.

AU - Klein, Sam

AU - Lebwohl, Benjamin

AU - Leung, John

AU - Lewis, James

AU - Nguyen, Linda

AU - Pandolfino, John

AU - Parrish, Carol Rees

AU - Scarlata, Kate

AU - Tack, Jan

AU - Frye, Jeanetta

AU - Harer, Kimberely

AU - Zevallos, Victor

AU - Srinivasan, Sachin

AU - Verma, Sandeep

AU - Jansson-Knodell, Claire

AU - Dia, Vermont

AU - Rifkin, Samara

AU - Pace, Laura

N1 - Funding Information: Conflicts of interest The authors have made the following disclosures: William Chey is a consultant for Biomerica, Commonwealth Diagnostics, IM Health Sciences, QOL Medical, and Ritter; and has received research grants from Biomerica , Commonwealth Diagnostics , Nestle , QOL Medical , and Zespri . Ashwin Ananthakrishan reports research support from Pfizer . Bibiana Garcia-Bailo is an employee of Nutrigenomix, Inc. Evan Dellon is a consultant for Adare, Alivio, Allakos, AstraZeneca, Banner, Calypso, Celgene/Receptos, Enumeral, EsoCap, Gossamer Bio, GSK, Regeneron, Robarts, and Shire; has received research support from Adare , Allakos , Celgene/Receptos, GSK , Regeneron , and Shire ; and has received educational grants from Banner and Holoclara . John DiBaise is a consultant for Allena Pharmaceuticals; an advisory board member for Zealand Pharmaceuticals, as well as Coram/CVS; and receives book royalties from McGraw-Hill, Springer, and CRC Press. Alessio Fasano is a consultant for Inova Diagnostics, Innovate Biopharma, and uBiome; is an advisory board member for Axial Biotherapeutics; receives research support from Takeda; has a speaking agreement with Mead Johnson Nutrition; and is a stockholder of Alba Therapeutics. Matthew J. Hamilton is a consultant for Takeda, Pfizer, Allakos and AbbVie. Sam Klein is a consultant for Pfizer and NovoNordisk; receives research support from Merck and Janssen ; is on the Scientific Advisory Board for Dannon/Yakult and Merck; and is a stockholder of Aspire Bariatrics. Benjamin Lebwohl is a consultant for Takeda and Innovate Biopharmaceuticals. John Leung is a consultant for Shire. James Lewis is a consultant for Crohn's & Colitis Foundation, IBD Plexus, Samsung Bioepis, Pfizer, Gilead, UCB, Bridge Biotherapeutics, Bristol-Myers Squibb, Arena Pharmaceuticals; and receives research support from Takeda , Janssen , Nestle Health Science and AbbVie . Linda Nguyen is a consultant for Allergan, Ironwood, and Nevro, and receives research support from Vanda . John Pandolfino is a consultant for Medtronic, Diversatek, Ironwood, and Tora-Ethicon; receives research support from Impleo ; receives a salary and speaking honorarium from Medtronic/Crospon for EndoFLIP; and holds stocks in Cropon and Trmedyne Laser. Carol Rees Parrish receives honoraria from Shire and Takeda for paid publications as well as from Shire for speaking. Kate Scarlata consults for FODY Food Company (a low FODMAP Company), Campbell Soup, Rachel Pauls Food, Casa de Sante Foods; and Nestle; and conducts sponsored talks at Nutrition Events. Jan Tack is a consultant for AlfaSigma, AlfaWassermann, Allergan, Alnylam, Arena, Christian Hansen, Danone, EA Pharma, Grünenthal, Ironwood, Kyowa Kirin, Menarini, Mylan, Neurogastrx, Neutec, Novartis, Noventure, Nutricia, Shionogi, Shire, Takeda, Theravance, Tramedico, Truvion, Tsumura, Zealand, and Zeria; receives research support from Shire, Tsumura , Abbott , Allergan , Ironwood , Kyowa Kirin , Menarini , Mylan , Novartis , Shire, Takeda, Truvion , and Zeria . Jeanetta Frye is a consultant to Isothrive. Claire Jansson-Knodell owns stocks in Exact Sciences, Bristol-Myers Squibb, Johnson & Johnson, and Eli Lilly. Laura Pace reports research from Vanda Pharmaceuticals. Sheila Crowe receives honoraria from UpToDate, New England Journal of Medicine, and Annals of Internal Medicine. All other authors report no conflicts of interest. Funding Information: Conflicts of interest The authors have made the following disclosures: William Chey is a consultant for Biomerica, Commonwealth Diagnostics, IM Health Sciences, QOL Medical, and Ritter; and has received research grants from Biomerica, Commonwealth Diagnostics, Nestle, QOL Medical, and Zespri. Ashwin Ananthakrishan reports research support from Pfizer. Bibiana Garcia-Bailo is an employee of Nutrigenomix, Inc. Evan Dellon is a consultant for Adare, Alivio, Allakos, AstraZeneca, Banner, Calypso, Celgene/Receptos, Enumeral, EsoCap, Gossamer Bio, GSK, Regeneron, Robarts, and Shire; has received research support from Adare, Allakos, Celgene/Receptos, GSK, Regeneron, and Shire; and has received educational grants from Banner and Holoclara. John DiBaise is a consultant for Allena Pharmaceuticals; an advisory board member for Zealand Pharmaceuticals, as well as Coram/CVS; and receives book royalties from McGraw-Hill, Springer, and CRC Press. Alessio Fasano is a consultant for Inova Diagnostics, Innovate Biopharma, and uBiome; is an advisory board member for Axial Biotherapeutics; receives research support from Takeda; has a speaking agreement with Mead Johnson Nutrition; and is a stockholder of Alba Therapeutics. Matthew J. Hamilton is a consultant for Takeda, Pfizer, Allakos and AbbVie. Sam Klein is a consultant for Pfizer and NovoNordisk; receives research support from Merck and Janssen; is on the Scientific Advisory Board for Dannon/Yakult and Merck; and is a stockholder of Aspire Bariatrics. Benjamin Lebwohl is a consultant for Takeda and Innovate Biopharmaceuticals. John Leung is a consultant for Shire. James Lewis is a consultant for Crohn's & Colitis Foundation, IBD Plexus, Samsung Bioepis, Pfizer, Gilead, UCB, Bridge Biotherapeutics, Bristol-Myers Squibb, Arena Pharmaceuticals; and receives research support from Takeda, Janssen, Nestle Health Science and AbbVie. Linda Nguyen is a consultant for Allergan, Ironwood, and Nevro, and receives research support from Vanda. John Pandolfino is a consultant for Medtronic, Diversatek, Ironwood, and Tora-Ethicon; receives research support from Impleo; receives a salary and speaking honorarium from Medtronic/Crospon for EndoFLIP; and holds stocks in Cropon and Trmedyne Laser. Carol Rees Parrish receives honoraria from Shire and Takeda for paid publications as well as from Shire for speaking. Kate Scarlata consults for FODY Food Company (a low FODMAP Company), Campbell Soup, Rachel Pauls Food, Casa de Sante Foods; and Nestle; and conducts sponsored talks at Nutrition Events. Jan Tack is a consultant for AlfaSigma, AlfaWassermann, Allergan, Alnylam, Arena, Christian Hansen, Danone, EA Pharma, Grünenthal, Ironwood, Kyowa Kirin, Menarini, Mylan, Neurogastrx, Neutec, Novartis, Noventure, Nutricia, Shionogi, Shire, Takeda, Theravance, Tramedico, Truvion, Tsumura, Zealand, and Zeria; receives research support from Shire, Tsumura, Abbott, Allergan, Ironwood, Kyowa Kirin, Menarini, Mylan, Novartis, Shire, Takeda, Truvion, and Zeria. Jeanetta Frye is a consultant to Isothrive. Claire Jansson-Knodell owns stocks in Exact Sciences, Bristol-Myers Squibb, Johnson & Johnson, and Eli Lilly. Laura Pace reports research from Vanda Pharmaceuticals. Sheila Crowe receives honoraria from UpToDate, New England Journal of Medicine, and Annals of Internal Medicine. All other authors report no conflicts of interest.An R13 travel grant was awarded by the National Institutes of Health (NIDDK) for the junior faculty who moderated sessions and collaborated on this meeting summary. Members of the Freston Conference Faculty: Ashwin Ananthakrishan,4 Bibiana Garcia-Bailo,5 Evan S. Dellon,6 John DiBaise,7 Alessio Fasano,8 Emily Haller,2 Matthew J. Hamilton,9 Sam Klein,10 Benjamin Lebwohl,11 John Leung,12,13 James Lewis,14 Linda Nguyen,15 John Pandolfino,16 Carol Rees Parrish,17 Kate Scarlata,18 Jan Tack,19 Jeanetta Frye,17 Kimberely Harer,20 Victor Zevallos,21 Sachin Srinivasan,22 Sandeep Verma,23 Claire Jansson-Knodell,24 Vermont Dia,25 Samara Rifkin,20 and Laura Pace26, 4Massachusetts General Hospital; 5University of Toronto and Nutrigenomix Inc; 6University of North Carolina School of Medicine; 7Mayo Clinic; 8Massachusetts General Hospital for Children; 9Brigham and Women's Hospital; 10Washington University School of Medicine; 11Columbia University Medical Center; 12Tufts University; 13New England Medical Center; 14University of Pennsylvania; 15Stanford University School of Medicine; 16Northwestern University; 17University of Virginia Health System; 18Boston University; 19KU Leuven; 20University of Michigan; 21St. Mary's University, UK; 22Kansas University School of Medicine; 23Sinai Hospital; 24Indiana University; 25University of Tennessee, Knoxville; and 26University of Utah.

PY - 2020/7

Y1 - 2020/7

UR - http://www.scopus.com/inward/record.url?scp=85088271379&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85088271379&partnerID=8YFLogxK

U2 - 10.1053/j.gastro.2020.03.036

DO - 10.1053/j.gastro.2020.03.036

M3 - Article

C2 - 32224128

AN - SCOPUS:85088271379

SN - 0016-5085

VL - 159

SP - 20

EP - 25

JO - Gastroenterology

JF - Gastroenterology

IS - 1

ER -